Advertisement

Insulin-inhibited and stimulated cultured vascular smooth muscle cell migration are related to divergent effects on protein phosphatase-2A and autonomous calcium/calmodulin-dependent protein kinase II

  • Ming Yang
    Affiliations
    Division of Nephrology and Hypertension, Department of Medicine, Medical School, University of Texas Health Science Center, Houston, United States
    Search for articles by this author
  • Andrew M. Kahn
    Correspondence
    Corresponding author at: University of Texas Medical School, MSB 4.107, 6431 Fannin Street, Houston, TX 77030, United States. Tel.: +1 713 500 6866; fax: +1 713 500 6882.
    Affiliations
    Division of Nephrology and Hypertension, Department of Medicine, Medical School, University of Texas Health Science Center, Houston, United States
    Search for articles by this author

      Abstract

      Insulin, in the permissive presence of nitric oxide (NO), stimulates cGMP production which inhibits autonomous calcium/calmodulin-dependent protein kinase II (CaM kinase II) thereby inhibiting cultured vascular smooth muscle cell (VSMC) migration. In the presence of angiotensin II (Ang II), insulin stimulates NAD(P)H oxidase activity leading to increased VSMC migration. We wished to see whether insulin-stimulated cGMP stimulates protein phosphatase-2A (PP-2A) thereby inhibiting autonomous CaM kinase II and migration, and whether insulin, in the presence of Ang II, inhibits PP-2A and stimulates autonomous CaM kinase II in a NAD(P)H oxidase-dependent manner. One nanomole per litre of insulin in the presence of NO, or 50 μmol/L 8-Br-cGMP stimulated PP-2A activity by 46 ± 6 and 247 ± 23%, respectively (both P < 0.05), and 8-Br-cGMP inhibited autonomous CaM kinase II activity by 67 ± 9% (P < 0.05) by a 10 nmol/L okadaic acid-sensitive pathway. Insulin plus Ang II inhibited PP-2A activity by 57 ± 7% (P < 0.05) and stimulated autonomous CaM kinase II activity by 120 ± 14% (P < 0.05), both by an apocynin-sensitive pathway. 8-Br-cGMP-inhibited VSMC migration was blocked by okadaic acid. It is concluded that insulin in the presence of NO stimulates cGMP which stimulates PP-2A activity causing inhibition of autonomous CaM kinase II activity and thus VSMC migration, and that insulin in the presence of Ang II inhibits PP-2A and stimulates autonomous CaM kinase II activities by a NAD(P)H oxidase-dependent mechanism which are associated with insulin-stimulated NAD(P)H oxidase-dependent migration.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stout R.W.
        Insulin and atheroma—20-year perspective.
        Diabetes Care. 1990; 13: 631-654
        • Asakura Y.
        • Suzuki M.
        • Nonogi H.
        • et al.
        Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
        J Cardiovasc Risk. 1998; 5: 331-334
        • Osani H.
        • Kanayama H.
        • Miyazaki Y.
        • et al.
        Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus.
        Am J Cardiol. 1998; 81: 698-701
        • Casscells W.
        Migration of smooth muscle and endothelia cells; critical events in restenosis.
        Circulation. 1992; 86: 723-729
        • Kahn A.M.
        • Allen J.C.
        • Seidel C.L.
        • Zhang S.
        Insulin inhibits migration of vascular smooth muscle cells with nitric oxide synthase.
        Hypertension. 2000; 35: 303-306
        • Zhang S.
        • Yang Y.
        • Kone B.C.
        • Allen J.C.
        • Kahn A.M.
        Insulin-stimulated cyclic GMP inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II.
        Circulation. 2003; 107: 1539-1544
        • Yang M.
        • Foster E.
        • Kahn A.M.
        Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells.
        Am J Hypertens. 2005; 18: 1329-1334
        • Lundberg M.S.
        • Curto K.A.
        • Bilato C.
        • Monticone R.E.
        • Crow M.T.
        Regulation of vascular smooth muscle migration by mitogen-activated protein kinase and calcium/calmodulin-dependent protein kinase II signaling pathways.
        J Mol Cell Cardiol. 1998; 30: 2377-2384
        • Pauly R.R.
        • Bilato C.
        • Sollott S.J.
        • et al.
        Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration.
        Circulation. 1995; 15: 1107-1115
        • Abraham S.T.
        • Benscoter H.
        • Schworer C.M.
        • Singer H.A.
        In situ Ca2+ dependence for activation of Ca2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells.
        J Biol Chem. 1996; 2: 2506-2513
        • Soderling T.R.
        • Chang B.
        • Brickey D.
        Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase II.
        J Biol Chem. 2001; 278: 3719-3722
        • Knapp J.
        • Aleth S.
        • Balzer F.
        • Schmitz W.
        • Neumann J.
        Calcium-independent activation of the contractile apparatus in smooth muscle of mouse aorta by protein phosphatase inhibition.
        Naunyn-Schmiedeberg's Arch Pharmacol. 2002; 366: 562-569
        • Colbran R.J.
        Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity.
        J Neurosci. 2004; 24: 8404-8409
        • Mishra-Gorur K.
        • Singer H.A.
        • Castellot J.J.
        Heparin inhibits phosphorylation and autonomous activity of Ca2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells.
        Am J Path. 2002; 161: 1893-1901
        • Rao R.K.
        • Clayton L.W.
        Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation.
        Biochem Biophys Res Commun. 2002; 293: 610-615
        • Griendling K.K.
        • Minieri C.A.
        • Ollerenshaw J.D.
        • Alexander R.W.
        Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
        Circ Res. 1994; 74: 1141-1148
        • Lassegue B.
        • Clempus R.E.
        Vascular NAD(P)H oxidases: specific features, expression, and regulation.
        Am J Physiol. 2003; 285: R277-R297
        • Cohen P.
        • Klumpp S.
        • Schelling D.L.
        An improved procedure for identifying and quantiating protein phosphatases in mammalian tissues.
        FEBS Lett. 1989; 250: 596-600
        • Knap J.
        • Boknik P.
        • Lüss I.
        • et al.
        The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.
        J Pharmacol Exp Ther. 1999; 289: 1480-1486
        • Kahn A.M.
        • Allen J.C.
        • Seidel C.L.
        • et al.
        Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential.
        Am J Physiol Endocrinol Metab. 2000; 278: E627-E633
        • Yang M.
        • Kahn A.M.
        Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
        Am J Hypertens. 2006; 19: 587-592
        • Hart B.A.
        • Simons J.M.
        Metabolic activation of phenols by stimulated neutrophils: a concept for a selective type of anti-inflammatory drug.
        Biotechnol Ther. 1992; 3: 119-135
        • Meyer J.W.
        • Schmitt M.E.
        A central role for the endothelial NADPH oxidase in atherosclerosis.
        FEBS Lett. 1992; 472: 1-4
        • Jacob A.
        • Molkentin J.D.
        • Smolenski A.
        • Lohmann S.M.
        • Begum N.
        Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs.
        Am J Physiol. 2002; 283: C704-C713
        • Low Wang C.C.
        • Gurevich I.
        • Draznin B.
        Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways.
        Diabetes. 2003; 52: 2562-2569
        • Zhuang D.
        • Ceacareanu A.C.
        • Lin Y.
        • et al.
        Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP.
        Am J Physiol. 2004; 286: H2103-H2112
        • Knapp J.
        • Bokník P.
        • Huke S.
        • et al.
        The mechanism of action of cantharidin in smooth muscle.
        Br J Pharmacol. 1998; 123: 911-919
        • Honkanen R.E.
        Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
        FEBS Lett. 1993; 330: 283-286
        • Moreno H.
        • Vega-Saenz de Miera E.
        • Nadal M.S.
        • Amarillo Y.
        • Rudy B.
        Modulation of Kv3 potassium channels expressed in CHO cells by a nitric oxide-activated phosphatase.
        J Physiol. 2001; 5303: 345-358
        • Zhou X.B.
        • Ruth P.
        • Schlossmann J.
        • Hofmann F.
        • Korth M.
        Protein phosphatase 2A is essential for the activation of Ca2+-activated K+ currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells.
        J Biol Chem. 1996; 271: 19760-19767
        • Howe C.J.
        • LaHair M.M.
        • McCubrey J.A.
        • Frankin R.A.
        Redox regulation of the calcium/calmodulin-dependent protein kinases.
        J Biol Chem. 2004; 279: 44573-44581
        • Nguyen A.
        • Peng C.
        • Cai H.
        Role of CaMKII in hydrogen perioxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells.
        FEBS Lett. 2004; 572: 307-313
        • Duff J.L.
        • Monia B.P.
        • Berk B.C.
        Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells.
        J Biol Chem. 1995; 270: 7161-7166
        • Graf K.
        • Xi X.
        • Yang D.
        • et al.
        Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.
        Hypertension. 1997; 29: 334-339